Sysmex (OTCMKTS:SSMXY) Shares Gap Down - Here's Why

Key Points

• Sysmex Corporation's stock opened significantly lower at $16.04 after closing at $16.52, indicating market volatility.
• The company reported a net margin of 10.56% and earnings per share of $0.12, missing estimates by $0.04 for the recent quarter.
• Sysmex's market capitalization stands at $10.57 billion, reflecting its significant presence in the diagnostics industry.

Sysmex Corporation ADR (OTCMKTS:SSMXY - Get Free Report)'s share price gapped down before the market opened on Monday . The stock had previously closed at $16.52, but opened at $16.04. Sysmex shares last traded at $16.81, with a volume of 2,227 shares trading hands.

Sysmex Stock Down 9.6%

The firm has a market cap of $8.68 billion, a P/E ratio of 24.63 and a beta of 1.15. The company's 50-day simple moving average is $16.79 and its 200 day simple moving average is $17.84. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.97 and a quick ratio of 2.30.

Sysmex (OTCMKTS:SSMXY - Get Free Report) last released its quarterly earnings results on Wednesday, May 14th. The company reported $0.12 EPS for the quarter, missing the consensus estimate of $0.16 by ($0.04). The company had revenue of $958.89 million during the quarter, compared to the consensus estimate of $991.22 million. Sysmex had a return on equity of 11.81% and a net margin of 10.56%. Research analysts anticipate that Sysmex Corporation ADR will post 0.57 EPS for the current fiscal year.

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.